BenevolentAI | Investor Presentation Deck | 19 slides

BenevolentAI · 2022-06
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

19
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
The slide uses a structured layout to categorize problems into three pillars: Expensive & high risk, Long R&D cycles, and Poor efficacy & high societal cost.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
04
The slide uses a process diagram to highlight the pain points of the traditional drug development pipeline.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
05
The slide uses a circular flywheel-style diagram to represent the platform's iterative nature.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
06
The slide uses a flywheel diagram to represent the iterative nature of their AI-driven drug discovery process.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
07
The slide outlines a proprietary drug discovery workflow.present_solution
Open slide detailLoop · Cost Of Inaction
08
The slide uses a process flow diagram to illustrate the business model.present_solution
Open slide detailBeat · Business ModelLoop · Cost Of Inaction
09
The chart uses a Gantt-style visualization to show progress from Target ID to Commercial stages.show_traction
Open slide detailBeat · Pipeline depth and progressionLoop · Cost Of Inaction
10
The slide uses a split-layout: left side defines the disease burden and market, right side defines the drug mechanism.frame_problem
Open slide detailLoop · Cost Of Inaction
11
Includes scientific data plots showing dose-dependent inhibition of TNF-a, IL-4, and CGRP.present_solution
Open slide detailLoop · Cost Of Inaction
12
The slide uses a process diagram to show the transition from Part A to Part B.show_traction
Open slide detailLoop · Quick Win Big Bet
13
Includes a breakdown of UC severity levels (64%, 31%, 5%) and a summary of the drug's mechanism and target patient population.frame_problem
Open slide detailLoop · Quick Win Big Bet
14
Includes a biological pathway diagram, a volcano plot for gene expression, and bar charts showing cytokine reduction.present_solution
Open slide detailLoop · Quick Win Big Bet
15
The slide uses a combination of a chronological timeline and a three-stage process framework.plan_implementation
Open slide detailLoop · Quick Win Big Bet
16
state_next_steps
17
The slide uses a hub-and-spoke diagram to link the company to its five capital allocation priorities.plan_implementation
18
plan_implementation
19
The chart compares actual/projected pipeline growth against an 'Industry Standard' benchmark line.show_traction